VERU INC. Impairment of Intangible Assets (Excluding Goodwill)
VERU INC. (VERU) reported Impairment of Intangible Assets (Excluding Goodwill) of $14.10 million for the 3-month period ending 2020-09-30, per its 10-K filed 2021-12-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2021-12-02
- VERU INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2020-09-30 was $14.10M.
- VERU INC. impairment of intangible assets (excluding goodwill) for fiscal 2020 was $14.10M.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|
| 2020-09-30 | $14.10M 10-K · filed 2021-12-02 | $14.10M 10-K · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |